Skip to content

Contrast-Enhanced Ultrasound in Evaluating Response to Intratumoral Injection Therapy for Advanced Solid Tumors

Contrast-Enhanced Ultrasound in Evaluating Response to Intratumoral Injection Therapy for Advanced Solid Tumors

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600121442
Enrollment
Unknown
Registered
2026-03-31
Start date
2026-04-08
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced Solid Tumors

Interventions

Gold Standard:RECIST version 1.1 criteria based on contrast-enhanced CT
Index test:Dynamic enhancement patterns and quantitative parameters of contrast-enhanced ultrasound (CEUS)

Sponsors

Langfang Campus, Cancer Hospital, Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Patients who voluntarily participate in the study and have signed the written informed consent form; (2) Age >=18 years; (3) Patients with solid tumors who meet the requirements for GCP clinical trials; (4) Patients scheduled to receive intratumoral injection therapy.

Exclusion criteria

Exclusion criteria: (1)Pregnant women or patients allergic to ultrasound contrast agents; (2)Patients who have previously received intratumoral injection therapy; (3)Patients who refuse or are unable to undergo contrast-enhanced ultrasound examination; (4)Patients with incomplete clinical pathological data or ultrasound imaging data.

Design outcomes

Primary

MeasureTime frame
Qualitative CEUS enhancement pattern;Quantitative CEUS parameters;Treatment response assessment;

Secondary

MeasureTime frame
Repeat measurement consistency;

Countries

China

Contacts

Public ContactFeng Li

Langfang Campus, Cancer Hospital, Chinese Academy of Medical Sciences

fyljasmine@126.com+86 152 0150 6514

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026